A subsequent clinical study on 52 patients with non-alcoholic fatty liver disease (NAFLD) found that synbiotic supplementation results in the inhibition of nuclear factor-κB (NF-κB) and a decreased production of TNF [97], thus indicating that the supplementation with synbiotics was associated with a reduction in inflammation. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.